Literature DB >> 16418255

From the archives of the AFIP: benign fibrous tumors and tumorlike lesions of the mesentery: radiologic-pathologic correlation.

Angela D Levy1, Jordi Rimola, Anupamjit K Mehrotra, Leslie H Sobin.   

Abstract

Mesenteric fibromatosis, sclerosing mesenteritis, inflammatory pseudotumor, and extrapleural solitary fibrous tumor constitute a loosely associated group of benign fibrous tumors and tumorlike lesions of the mesentery. These lesions are linked histologically by the presence of fibroblasts or fibrosis and anatomically by their location within the mesentery. Although rare, and distinctly different in pathogenesis and biologic behavior, these fibrous lesions have pathologic and radiologic features that overlap with one another and with more common neoplastic and nonneoplastic lesions of the mesentery. Mesenteric fibromatosis is a locally aggressive, benign proliferative process that may occur sporadically or in association with familial adenomatous polyposis. It most frequently manifests as a focal mesenteric mass and may simulate lymphoma, metastatic disease, or a soft-tissue sarcoma. Sclerosing mesenteritis is a rare idiopathic disorder that most commonly produces a stellate mass within the mesentery and should be differentiated from metastatic disease, specifically metastatic carcinoid, because it frequently responds to conservative or medical management. Inflammatory pseudotumor (inflammatory myofibroblastic tumor) is a benign, chronic inflammatory disorder of unknown cause that manifests as a solid mesenteric mass, indistinguishable from malignancy. Extrapleural solitary fibrous tumor is a tumor of submesothelial origin that is identical to the solitary fibrous tumor of the pleura. When located in the mesentery or peritoneal cavity, extrapleural solitary fibrous tumor has an imaging pattern that must be differentiated from metastatic disease, soft-tissue sarcomas, and other benign and malignant neoplasms of the mesentery and peritoneum. Knowledge of this group of benign fibrous tumors and tumorlike lesions of the mesentery is important in the preoperative evaluation of a mesenteric mass.

Entities:  

Mesh:

Year:  2006        PMID: 16418255     DOI: 10.1148/rg.261055151

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  53 in total

1.  Sclerosing Mesenteritis: Diverse clinical presentations and dissimilar treatment options. A case series and review of the literature.

Authors:  Konstantinos Vlachos; Fotis Archontovasilis; Evangelos Falidas; Stavros Mathioulakis; Stefanos Konstandoudakis; Constantinos Villias
Journal:  Int Arch Med       Date:  2011-06-02

2.  Inflammatory pseudotumor of the omentum.

Authors:  Kushaljit Singh Sodhi; Vivek Virmani; Amanjit Bal; Akshay Kumar Saxena; Ram Samujh; Niranjan Khandelwa
Journal:  Indian J Pediatr       Date:  2010-06-08       Impact factor: 1.967

3.  Gardner syndrome complicated with hydronephrosis. A case report.

Authors:  Paolo Cabassa; Mario Morone; Enza Gatti; Mariapaola Narbone; Roberto Maroldi
Journal:  J Radiol Case Rep       Date:  2010-03-01

4.  A 13 kg intra-abdominal mass: a case of mesenteric fibromatosis.

Authors:  M Menegazzo; M Tonello; R Bardini
Journal:  Updates Surg       Date:  2012-03-13

5.  Mesenteric desmoid tumour masquerading as a fat-containing cystic mass.

Authors:  C H Tan; U Pua; K H Liau; H Y Lee
Journal:  Br J Radiol       Date:  2010-10       Impact factor: 3.039

Review 6.  [Benign mesenchymal tumors of the abdomen].

Authors:  P A Kupczyk; G M Kukuk
Journal:  Radiologe       Date:  2018-01       Impact factor: 0.635

7.  Omental fibromatosis treated by laparoscopic wide surgical resection.

Authors:  David Martin; Mirza Muradbegovic; Snezana Andrejevic-Blant; David Petermann; Luca Di Mare
Journal:  Intractable Rare Dis Res       Date:  2018-02

8.  Intra-abdominal Desmoid-Type Fibromatosis Mimicking Diverticulitis With Abscess: A Case Report.

Authors:  Sachie Omori; Shuhei Ito; Koichi Kimura; Takahiro Higashi; Kippei Ohgaki; Shinichiro Maehara; Toshihiko Nakamura; Takefumi Ohga; Eisuke Adachi; Yoichi Ikeda; Yoshihiko Maehara
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

9.  CTGF, intestinal stellate cells and carcinoid fibrogenesis.

Authors:  M Kidd; I M Modlin; M D Shapiro; R L Camp; S M Mane; W Usinger; J R Murren
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

Review 10.  Fibrosis and carcinoid syndrome: from causation to future therapy.

Authors:  Maralyn Druce; Andrea Rockall; Ashley B Grossman
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.